IRON · Disc Medicine, Inc.
$78.84
-1.17 (-1.46%)
At close · Aug 14
Market Cap
$3.03B
Shares
38.39M
Positioning
Aug 21, 2026 · 5 days to expiryPut / call OI
—
dated and unknown snapshot sessions
Open interest
—
dated and unknown snapshot sessions
Volume
—
dated and unknown snapshot sessions
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | 0.1% | 1 | — | — | — | — | — | 0 | |
| 0 | — | 265.9% | 0.991 | — | — | — | — | — | 0 | |
| 0 | — | 0.1% | 1 | — | — | — | — | — | 0 | |
| 0 | — | 183% | 0.987 | — | — | -0.041 | 241.7% | — | 0 | |
| 3 | 3 | 130.5% | 0.993 | $23.53 | — | -0.049 | 200.2% | — | 0 | |
| 0 | — | — | — | — | — | -0.06 | 160.4% | — | 0 | |
| 7 | 7 | 0.1% | 1 | $12.30 | $0.86 | -0.083 | 124.3% | 2 | 2 | |
| 5 | 10 | — | — | $9.30 | $2.90 | -0.095 | 79.6% | 10 | 10 | |
| 17 | 16 | 49.6% | 0.812 | $4.45 | $4.50 | -0.197 | 51.8% | 40 | 140 | |
| 2k | 3 | 49.1% | 0.416 | $3.40 | $9.10 | -0.59 | 47.1% | 1 | 1 | |
| 581 | 2 | 47.4% | 0.096 | $1.05 | $8.80 | -0.886 | 51.5% | 2 | 2 | |
| 20 | 10 | 73.2% | 0.068 | $0.86 | — | — | — | — | 0 | |
| 0 | — | 112.5% | 0.09 | — | — | — | — | — | 0 | |
| 0 | — | 136% | 0.078 | — | — | -0.971 | 105.4% | — | 0 | |
| 0 | — | 155% | 0.07 | — | — | -0.974 | 122.3% | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Jun 26, 2026–Aug 12, 2026; 18 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.
Key facts
CIK
1816736
CUSIP
254604101
13F (30d)
214 filings
212 filers
Visit website
Investor relations